NantCell's Unattributed - II Round

NantCell raised a round of funding on September 11, 2015.

NantCell, a wholly-owned subsidiary of NantWorks, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by developing molecularly targeted …

Articles about NantCell's Unattributed - II Round: